Top Page | English | 简体中文 | 繁體中文 | 한국어 | 日本語
Tuesday, 19 October 2021, 15:00 HKT/SGT
Share:
    

Source: Agilex Biolabs
Agilex Biolabs Shares How to Select the Right Bioanalytical Tools for Immuno-oncology and Vaccines Studies - OCT Webinar

ADELAIDE, AUS, Oct 19, 2021 - (ACN Newswire) - Agilex Biolabs, the Australian regulated bioanalytical and toxicology laboratory facilities for clinical trials is presenting a new webinar entitled "Getting it right! Considerations for Immuno-oncology and Vaccine Studies and the Bioanalytical Tools used" in partnership with Outsourcing Clinical Trials (OCT).

Agilex Biolabs' Director, Immunoassay, Kurt J. Sales (B.Sc; B.Sc (MED) Hons; M.Sc, Ph.D, PGCM) said:

"Choosing the right bioanalytical platform for your immunology or vaccines clinical trial is critical to data collection. But navigating the intricate bioanalytical process and selection of assay platforms can be difficult. This webinar covers these platforms in detail and the selection process."

Agilex Biolabs is the largest regulated bioanalytical laboratory in Australia with over 24 years' experience in early phase clinical trials with a track record of enabling the movement of new drug entities to market.

Agilex Biolabs specialises in pharmacokinetics, pharmacodynamics, and biomarker evaluation, which is key to understanding the drug absorption, distribution, metabolism, and excretion as well as target engagement and efficacy of the drug during clinical development.

"This webinar will demystify the bioanalytical requirements for clinical studies and will discuss the most common bioanalytical platforms used during clinical trials to measure vaccine responses and levels of inflammatory mediators in biological fluids," said Dr. Sales.

Key Learning Objectives
- Learn how to determine the right bioanalytical platform for your immunology or vaccines clinical trial
- Understand what do these bioanalytical platforms look like in use
- Understand the process of selecting the right bioanalytical platform
- Demystify the bioanalytical requirements for clinical studies

The webinar will also cover Australian research, and regulatory and clinical infrastructure, which provides a favorable environment for rapid vaccine development. It will also include discussion of a case study for rapid vaccine development based on non-clinical research conducted with a novel COVID-19 protein subunit vaccine.

Register Here https://bit.ly/3aPlWsx
Date: 4 November
Time: 2PM London/3PM CET
Speaker: Dr Kurt Sales: Director, Immunoassay, Agilex Biolabs

Agilex Biolabs' world-class laboratories feature state-of-the-art equipment including Gyrolab Xplore, MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow cytometer and digital droplet quantitative real-time RT-PCR.

The company offers services for both small molecules and biologics for PK, immunogenicity (PD) and biomarker bioanalysis utilising the two platforms of LC-MS/MS and Immunoassay.

Australian clinical trials have remained open for business and Agilex Biolabs is a designated essential service so clients can be assured of study continuity.

Agilex Biolabs has more than 140 staff which includes 85 dedicated laboratory staff, and supports client pharma and biotech companies from US, Europe and APAC.

Book a confidential briefing with our scientists before you start your next clinical trial. https://calendly.com/agilexbiolabs/30min

About Agilex Biolabs https://www.agilexbiolabs.com/

Agilex Biolabs, the Australian specialist bioanalytical and toxicology laboratory facilities for clinical trials, has more than 24 years' experience in performing regulated bioanalysis, including quality method development, method validation and sample analysis services. It has successfully supported hundreds of preclinical and clinical trials from around the world where customers choose Australia for the streamlined regulatory process and access to the world's most attractive R&D rebate of more up to 43.5% on clinical trial work conducted in Australia.

Agilex Biolabs also offers toxicology services through its company TetraQ.

Agilex Biolabs has the leading certifications including OECD GLP Recognition with NATA (Australian Government OECD GLP Compliance monitoring authority) and ISO 17025 Accreditation for global recognition.

The company has recently expanded its main labs by more than 30% to accommodate biotech demand from APAC and the USA. In addition it has launched a new Immunobiology lab - watch the video here. https://www.agilexbiolabs.com/launch-of-immunobiology-laboratory/

Agilex Biolabs specialises in bioanalysis of small molecules and biologics for PK, immunogenicity, biomarkers and immunological pharmacodynamics assessments utilising LC-MS/MS, immunoassay (Mesoscale, Gyrolab, Luminex) and flow cytometry (BD FACSymphony A3, 20 colour cell analyser).

Agilex offers pharmacodynamics services that include immunobiology services using the latest state-of-the-art technology to support immunology, cell biology and mode of action assays, including:
- Immunophenotyping
- Receptor occupancy
- Cytokine release assays (whole blood or PBMC stimulation assays) and cytokine/biomarker profiling
- PBMC assays and cellular mechanism of action assays

Agilex Biolabs Media Contact:
Kate Newton
Media@AgilexBiolabs.com


Topic: Press release summary
Source: Agilex Biolabs

Sectors: Healthcare & Pharm, Clinical Trials
http://www.acnnewswire.com
From the Asia Corporate News Network


Copyright © 2021 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.



Agilex Biolabs
Sept 24, 2021 09:00 HKT/SGT
Agilex Biolabs Announced as Citeline Award Finalist for COVID-19 Vaccine Toxicology Preclinical Research
Aug 26, 2021 13:00 HKT/SGT
Agilex Biolabs Partners with Endpoints News for the First Webinar on Rapid Vaccine Development in Australia
July 14, 2021 17:00 HKT/SGT
Premier of South Australia Launches $1.5m Vaccine and Immunobiology State-of-the art Laboratory for APAC Clinical Trials
May 31, 2021 13:00 HKT/SGT
Agilex Biolabs and Gyros Protein Technologies Partner for BioAnalysis Zone Webinar on Singlicate Analysis
May 21, 2021 11:00 HKT/SGT
Agilex Biolabs Partners with Endpoints News on Deconvoluting Inflammation and Immunology for Clinical Trials
May 17, 2021 21:00 HKT/SGT
Agilex Biolabs' Toxicology Tapped for SARS-CoV-2 Vaccine Research
Apr 30, 2021 13:00 HKT/SGT
Agilex Biolabs Congratulates Bionomics Limited on BNC210 PK Results
Apr 29, 2021 04:00 HKT/SGT
Agilex Biolabs and B2S Life Sciences on Immunoassay Bioanalysis for Clinical Trials
Apr 7, 2021 15:00 HKT/SGT
Agilex Biolabs acquires leading biolab TetraQ for APAC Expansion Plans
Mar 22, 2021 08:00 HKT/SGT
Agilex Biolabs Showcases Advanced Immunoassay and Immunobiology Services at Bio-Europe Spring 2021
More news >>
 News Alerts
Copyright © 2021 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: